ARYx Therapeutics files for $86.25 million IPO

WASHINGTON Thu Aug 30, 2007 5:44pm EDT

WASHINGTON Aug 30 (Reuters) - Biopharmaceutical company ARYx Therapeutics Inc filed with regulators on Thursday to raise up to $86.25 million in an initial public offering of common stock.

The company said in a registration statement with the U.S. Securities and Exchange Commission that Morgan Stanley, CIBC World Markets, Jefferies and Co, and Leerink Swann & Co are underwriting the IPO.

ARYx has applied to list its stock on Nasdaq under the symbol "ARYX" ARYX.O.